- Home
- PRCH vs AVIR Comparison
PRCH vs AVIR Comparison
Compare PRCH & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRCH
- AVIR
- Stock Information
- Founded
- PRCH 2012
- AVIR 2012
- Country
- PRCH United States
- AVIR United States
- Employees
- PRCH N/A
- AVIR N/A
- Industry
- PRCH Computer Software: Prepackaged Software
- AVIR Medicinal Chemicals and Botanical Products
- Sector
- PRCH Technology
- AVIR Health Care
- Exchange
- PRCH Nasdaq
- AVIR Nasdaq
- Market Cap
- PRCH 462.6M
- AVIR 247.5M
- IPO Year
- PRCH N/A
- AVIR 2020
- Fundamental
- Price
- PRCH $5.66
- AVIR $3.25
- Analyst Decision
- PRCH Buy
- AVIR Hold
- Analyst Count
- PRCH 8
- AVIR 1
- Target Price
- PRCH $5.34
- AVIR $6.88
- AVG Volume (30 Days)
- PRCH 2.9M
- AVIR 503.8K
- Earning Date
- PRCH 11-07-2024
- AVIR 11-07-2024
- Dividend Yield
- PRCH N/A
- AVIR N/A
- EPS Growth
- PRCH N/A
- AVIR N/A
- EPS
- PRCH N/A
- AVIR N/A
- Revenue
- PRCH $452,099,000.00
- AVIR N/A
- Revenue This Year
- PRCH $6.31
- AVIR N/A
- Revenue Next Year
- PRCH N/A
- AVIR N/A
- P/E Ratio
- PRCH N/A
- AVIR N/A
- Revenue Growth
- PRCH 19.04
- AVIR N/A
- 52 Week Low
- PRCH $1.05
- AVIR $2.75
- 52 Week High
- PRCH $6.04
- AVIR $4.60
- Technical
- Relative Strength Index (RSI)
- PRCH 62.85
- AVIR 53.42
- Support Level
- PRCH $4.32
- AVIR $3.10
- Resistance Level
- PRCH $6.04
- AVIR $3.32
- Average True Range (ATR)
- PRCH 0.64
- AVIR 0.15
- MACD
- PRCH -0.08
- AVIR 0.03
- Stochastic Oscillator
- PRCH 78.13
- AVIR 88.50
About PRCH Porch Group Inc.
Porch Group Inc is a vertical software company reinventing the home services and insurance industries. It has two reportable segments: The vertical Software segment provides software and services to home services companies. The Vertical Software segment software and services provide inspection, mortgage, and title companies on a subscription and transactional basis, several key businesses, including inspection software and services, title insurance software, mortgage software, moving services, mover and homeowner marketing, and measurement software for roofers. The insurance segment provides consumers with insurance and warranty products to protect their homes, earning revenue through premiums collected on policies, policy fees, and commissions.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).